Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced that Derek Hicks was appointed CEO. With more than 25 years of leadership in the pharmaceutical and biotech sectors, Derek brings a strong track record of transformative business development and experience in a wide range of disease areas, including oncology.
Nevan Krogan, Kevan Shokat, and Natalia Jura are the UCSF co-founders.